<DrugInformationSummary id="CDR0000813502"><DrugInfoMetaData><DrugInfoType>Brief</DrugInfoType><DrugInfoAudience>Patients</DrugInfoAudience><DrugInfoDescription>This page contains brief information about niraparib tosylate monohydrate and abiraterone acetate
         and a collection of links to more information about the use of 
         this drug combination, research results, and ongoing clinical trials.
  </DrugInfoDescription><DrugInfoURL xref="https://www.cancer.gov/about-cancer/treatment/drugs/niraparib-tosylate-monohydrate-and-abiraterone-acetate">Niraparib Tosylate Monohydrate and Abiraterone Acetate</DrugInfoURL><FDAApproved>Yes</FDAApproved><TerminologyLink ref="CDR0000811466">niraparib tosylate monohydrate and abiraterone acetate</TerminologyLink><GlossaryLink ref="CDR0000813463">niraparib tosylate monohydrate and abiraterone acetate</GlossaryLink><USBrandNames><USBrandName>Akeega</USBrandName></USBrandNames><PronunciationInfo><TermPronunciation>nih-RA-puh-rib TOH-suh-layt MAH-noh-HY-drayt â€¦ A-bih-RA-teh-rone A-seh-tayt</TermPronunciation><MediaLink ref="CDR0000814899" type="audio/mpeg" alt="" language="en" id="_3"/><MediaLink ref="CDR0000814900" type="audio/mpeg" alt="" language="es" id="_4"/></PronunciationInfo><FDAExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8245a990-3268-4613-b5c5-9537858a1eb9&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</FDAExternalRef></DrugInfoMetaData><DrugInfoTitle>Niraparib Tosylate Monohydrate and Abiraterone Acetate</DrugInfoTitle><Section id="_FDA"><Para><ExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8245a990-3268-4613-b5c5-9537858a1eb9&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</ExternalRef></Para></Section><Section id="_1"><Title>Use in Cancer</Title>                                                              
  <Para id="_2">Niraparib tosylate monohydrate and abiraterone acetate is approved to be used with <GlossaryTermRef href="CDR0000045492" dictionary="Cancer.gov" audience="Patient">prednisone</GlossaryTermRef> to treat:</Para>                          
  <ItemizedList Style="bullet" id="_3">
   <ListItem><Strong><GlossaryTermRef href="CDR0000445079" dictionary="Cancer.gov" audience="Patient">Prostate cancer</GlossaryTermRef></Strong> that has spread to other parts of the body and is <GlossaryTermRef href="CDR0000753525" dictionary="Cancer.gov" audience="Patient">castrate resistant</GlossaryTermRef> (has not responded to treatments that lower <GlossaryTermRef href="CDR0000045581" dictionary="Cancer.gov" audience="Patient">testosterone</GlossaryTermRef> levels). It is used in adults who have certain <GlossaryTermRef href="CDR0000046063" dictionary="Cancer.gov" audience="Patient">mutations</GlossaryTermRef> in the <GeneName><GlossaryTermRef href="CDR0000046047" dictionary="Cancer.gov" audience="Patient">BRCA1</GlossaryTermRef></GeneName> or <GeneName><GlossaryTermRef href="CDR0000046742" dictionary="Cancer.gov" audience="Patient">BRCA2</GlossaryTermRef></GeneName> gene.</ListItem>
   
   </ItemizedList>
  <Para id="_5">Niraparib tosylate monohydrate and abiraterone acetate is a fixed-dose combination of niraparib tosylate monohydrate and abiraterone acetate. This form may work better than either drug alone. For more information that may apply to these drugs, see the Drug Information Summaries for <DrugRef href="CDR0000788257" url="/about-cancer/treatment/drugs/niraparibtosylatemonohydrate">Niraparib Tosylate Monohydrate</DrugRef> and <DrugRef href="CDR0000700207" url="/about-cancer/treatment/drugs/abirateroneacetate">Abiraterone Acetate</DrugRef>.</Para>
 </Section><Section id="_About"><Title>More About Niraparib Tosylate Monohydrate and Abiraterone Acetate</Title><Para id="_Dict_1"><ExternalRef xref="https://www.cancer.gov/publications/dictionaries/cancer-drug/def/811466">Definition from the NCI Drug Dictionary</ExternalRef> - Detailed scientific definition and other names for this drug.</Para>

<Para id="_About_8.15">MedlinePlus Information on <ExternalRef xref="https://medlineplus.gov/druginfo/meds/a623037.html">Niraparib Tosylate Monohydrate and Abiraterone Acetate</ExternalRef> - A lay language summary of important information about this drug that may include the following:</Para>
<ItemizedList Style="bullet" id="_About_9.16"><ListItem>warnings about this drug,</ListItem><ListItem>what this drug is used for and how it is used,</ListItem><ListItem>what you should tell your doctor before using this drug,</ListItem><ListItem>what you should know about this drug before using it, </ListItem><ListItem>other drugs that may interact with this drug, and</ListItem><ListItem>possible side effects.  </ListItem></ItemizedList><Para id="_About_10.17">Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for.  This patient information sheet applies only to approved uses of the drug.  However, much of the information may also apply to unapproved uses that are being studied.</Para></Section><Section id="_Research"><Title>Research Results and Related Resources</Title><Para><ExternalRef xref="https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies">Targeted Therapy to Treat Cancer</ExternalRef></Para></Section><Section id="_ClinicalTrial_1"><Title>Clinical Trials Accepting Patients</Title><Para id="_ClinicalTrial_2"><ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials/intervention/C191876">Find Clinical Trials for Niraparib Tosylate Monohydrate And Abiraterone Acetate</ExternalRef> - Check for trials from NCI's list of cancer clinical trials now accepting patients.</Para></Section> 
  <DrugInfoDisclaimer>


<Para id="_Disclaimer_4"><Strong>Important: </Strong>The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.
</Para></DrugInfoDisclaimer> 
  <DateFirstPublished>2023-08-24</DateFirstPublished><DateLastModified>2023-10-13</DateLastModified></DrugInformationSummary>
